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1343thrombuswas present in 6 of 10 SVGs at baseline versus
1 of 10 SVGs at 12 months (Figure 1C). Mean thrombus
area at baseline imaging was 0.37  0.28 mm2. A
double-layer appearance was identiﬁed by OCT
imaging in the wall of all studied SVGs at the 12-
month follow-up. The median thickness of the inner
layer was 0.23 mm (interquartile range: 0.20 to 0.28
mm), and its area was 3.73 mm2 (interquartile range:
2.79 to 4.92 mm2), representing 25% (interquartile
range: 22% to 29%) of the total vessel cross-sectional
area.
Three-dimensional (3D) SVG reconstruction was
performed using a previously validated method-
ology on the basis of the 3D luminal centerline
derived from angiographic projections (1,2). The ob-
tained 3D lumen reconstructions were then used for
assessing the local endothelial shear stress (ESS) dis-
tribution by employing computational ﬂuid dy-
namics, as previously described (3). Baseline low ESS
was associated with: 1) the largest decrease in lumen
area (p < 0.001 vs. moderate and high ESS); 2) the
largest increase in plaque burden (p ¼ 0.011 vs. high
ESS); and 3) augmented ﬁbrous neointimal area, as
represented by the inner wall layer area at follow-up
(p ¼ 0.020 vs. moderate ESS and p ¼ 0.009 vs. high
ESS) (Figure 1D).
In summary, during the ﬁrst year after CABG, SVGs
undergo signiﬁcant lumen loss due to a combination
of wall thickening and negative remodeling. SVG
segments with the lowest ESS develop the largest
negative remodeling and neointima formation. These
ﬁndings provide important insights into the patho-
genesis of early SVG failure.Anna P. Kotsia, MD
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culation 2012;126:172–81.3D Transthoracic Echocardiography Provides
Accurate Cross-Sectional Area of the RV
Outﬂow TractMeasurement of the cross-sectional area (CSA) of the
right ventricular outﬂow tract (RVOT) has been
required to calculate stroke volume, especially for
estimation of the pulmonary blood ﬂow/systemic
blood ﬂow ratio. Current guidelines of the American
Society of Echocardiography state that the CSA should
be calculated using the RVOT diameter measured in
either the parasternal long-axis view or parasternal
short-axis view. Recently, the shape of the RVOT has
been reported to be oval when using 3-dimensional
(3D) transesophageal echocardiography (1); however,
the dynamic change of RVOT geometry in a cardiac
cycle has not been well validated with any
modality. The aim of this study was to assess
morphological and dynamic features of the RVOT
using multidetector computed tomography (MDCT)
and to compare the CSA of the RVOT obtained by
MDCT and by 3D or 2-dimensional (2D) transthoracic
echocardiography (TTE).
A total of 20 patients with clinically indicated
contrast MDCT were prospectively enrolled between
May and September 2014 at Tokushima University
Hospital. This study was conducted in accordance
with the Declaration of Helsinki, was approved by the
Institutional Review Board of the University of
Tokushima, and each subject gave written informed
consent. The MDCT examination was performed
using a 320-MDCT scanner (Aquilion ONE, Toshiba
Medical Systems, Tokyo, Japan). Retrospective
FIGURE 1 Correlations Between RVOT-CT and Echocardiography-Derived RVOT CSAs
The RVOT CSA obtained from 3-dimensional echocardiography (RVOT3D) correlated better with the RVOT-CT compared with those calculated
by RVOT long-axis diameter (RVOTlax), RVOT short-axis diameter (RVOTsax), and both (RVOToval).
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1344electrocardiography-gated MDCT was performed; 10
phases of images were reconstructed at a 10% R-R
interval. The RVOT was manually traced in the
double-oblique transverse view, and the CSA (RVOT-
CT) was measured at just below the pulmonary
annulus in all 10 phases (0% to 90% R-R interval).
Echocardiographic studies were performed using the
iE33 ultrasound imaging system (Philips Medical
Systems, Andover, Massachusetts). We measured the
long- and short-axis diameters of the RVOT in early
systole by a 2D probe and calculated the CSA using
each diameter, assuming that the RVOT is circular
(RVOTsax, RVOTlax) and using both diameters,
assuming that the RVOT is oval (RVOToval). The
RVOT CSA in the same cardiac phase was also
measured ofﬂine from the 3D dataset obtained by a 3D
probe (RVOT3D). Three patients were excluded from
this analysis because of poor image quality.
The RVOT CSA changed dynamically in a cardiac
cycle. The pulmonary valve opened from 10% to 30%
phases, and the maximum CSA was deﬁned in the
10% phase. Figure 1 shows comparisons among
various CSAs obtained by multimodalities (MDCT,
3D-TTE, and 2D-TTE). The RVOTsax underestimatedthe RVOT-CT (bias: 105.3 mm2), and there was no
signiﬁcant correlation between them (r ¼ 0.08,
p ¼ 0.75). The RVOTlax overestimated the RVOT-CT
(bias: þ111.3 mm2), and there was a modest
correlation between them (r ¼ 0.59, p ¼ 0.01). The
RVOToval had a small bias (bias: 13.5 mm2)
compared with the RVOT-CT, but there was no
signiﬁcant correlation between them (r ¼ 0.41, p ¼
0.11). The correlation between the RVOT3D and the
RVOT-CT was excellent (r ¼ 0.92, p < 0.001) with
less bias (bias: þ24.9 mm2).
The present study is the ﬁrst to demonstrate the
morphological and dynamic features of RVOT CSA by
MDCT. The CSA of the RVOT calculated by the di-
ameters in either view of 2D-TTE may be inaccurate in
some cases; the 3D-TTE provides more accurate
measurement of the parameter.Naoko Sawada, MD
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Mellitus: Are We on the Wrong Track?Wehave readwith great interest the recently published
article by Jensen et al. (1) about the 2-dimensional
mechanics in a large cohort of patients with type 1
diabetes mellitus (T1DM). The investigators reported
signiﬁcant difference in left ventricular (LV) global
longitudinal strain (GLS) between the control subjects
and the T1DM subjects with albuminuria, whereas the
diabetic patients and those with normoalbuminuria
have similar GLS as the healthy control subjects do,
even though these patients have had T1DM without
tight glycemic control (glycosylated hemoglobin
>8%) for more than 2 decades.
We would like to discuss several important points
of this investigation. The absolute value of GLS in the
control group is somewhat lower than expected for
the healthy mid-age population. Interestingly, dia-
stolic blood pressure and LV mass index are higher in
the control group than in the T1DM patients, espe-
cially than in the T1DM subjects with normoalbumi-
nuria, probably due to medical therapy.
The other important issue is the lack of association
between the usage of various medications and LV
mechanical remodeling in T1DM. The investigators
found that the treatment of statins, beta-blockers,
calcium-channel blockers, angiotensin-converting
enzymes, and angiotensin II inhibitors or diuretics is
not associated with any improvement of GLS in the
diabetic population. The data on this topic are scarce
and inconsistent, and this kind of investigation with a
large population of uncomplicated diabetic patients
has been waiting for a long time. The previous in-
vestigations showed that all these drugs improve LV
structure (reducing LVmass) and systolic and diastolic
function. Is it possible that they are completely inef-
fective for improvement of LV longitudinal function?Previously it was shown that statins improve LV
longitudinal function and that was evaluated using
different imaging techniques than speckle tracking
(2). Mizuguchi et al. (3) reported that telmisartan
signiﬁcantly improved GLS in hypertensive patients,
but only after 12 months. This ﬁnding raises
the question about the duration of therapy in the
present study, which was not been presented. Perhaps
longer duration of therapy would change the
results. Furthermore, Motoki et al. (4) recently showed
that calcium-channel blockers also have favorable
inﬂuence on GLS, even after only 3 months of therapy.
Beta-1 blockade, induced by bisoprolol, results in the
reduction of GLS (5). However, the percentage of the
T1DM patients who used beta-blockers in the present
study is not high enough to change the ﬁnal result,
especially in the subjects with normoalbuminuria.
Jensen et al. (1) showed that the usage of any of the
medications was not independently associated with
GLS. However, the present multivariate model consists
of some variables that interact (systolic and diastolic
blood pressure, body mass index and LV mass index).
It would be helpful to perform a multivariate analysis
considering the inﬂuence of the variables from model
3 on LV mass index and E/e0 in order to evaluate the
effect of different medications on LV structure and
diastolic function in this population.
The Thousand & 1 Study raises many questions that
need to be resolved and conﬁrmed, but it certainly
represents a solid ground for further investigations.Marijana Tadic, MD, PhD*
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